Clinilabs is pleased to announce its partnership with InTandem Capital Partners, a leading healthcare-focused private equity firm, to support our growth as we drive to become the preeminent provider of CNS drug and device development services industry-wide.
Gary Zammit, PhD, President & CEO of Clinilabs states, “I am pleased to announce that Clinilabs has partnered with InTandem to pursue the next stages of our growth. Clinilabs’ decision to partner came down to the people at InTandem. InTandem shares our vision for the Company, has deep expertise in the sector, and provides value-added operating resources that we sought to build our Company.”
To read the full press release visit: https://lnkd.in/e4NubQwZ
